Tao Ye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tao Ye has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Linglin Sun
The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China
2 shared publications- Qiang Li
Huazhong University of Science and Technology
2 shared publications Baoqin Wang
The Affiliated People’s Hospital of Ningbo University
1 shared publicationH. Li
Department of Radiology, The Affiliated People' S Hospital of Ningbo University, Ningbo 315040, China
1 shared publicationH. Xu
Department of Radiology, The Affiliated People' S Hospital of Ningbo University, Ningbo 315040, China
1 shared publicationJ. Li
Department of Radiology, The Affiliated People' S Hospital of Ningbo University, Ningbo 315040, China
1 shared publication
Latest Publications
- Open Access
- 22 July 2026
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 25
Research Progress on Dual-Modal Fluorescence-MRI Molecular Imaging of Molecular Probes in Breast Cancer
Breast cancer (BC), as a prevalent malignancy among women worldwide, requires early and precise diagnosis to improve patient prognosis. This review systematically summarizes the recent research progress of fluorescence -magnetic resonance (MR) dual-modal molecular probes in the diagnosis and treatment of breast cancer, focuses on introducing three major design strategies of the probes, and analyzes their synergistic advantages in tumor localization, metastatic lesion detection, intraoperative navigation, dynamic drug monitoring, and other aspects. Studies have shown that by combining the high-resolution anatomical information of MRI with the high-sensitivity dynamic tracking of fluorescence imaging (FI), FI-MRI dual-modal molecular imaging significantly improves the accuracy of early diagnosis and treatment visualization, and can provide an important reference for formulating precise diagnosis and treatment strategies for breast cancer.
- 22 July 2026
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 25
Open AccessResearch Progress on Dual-Modal Fluorescence-MRI Molecular Imaging of Molecular Probes in Breast Cancer
Breast cancer (BC), as a prevalent malignancy among women worldwide, requires early and precise diagnosis to improve patient prognosis. This review systematically summarizes the recent research progress of fluorescence -magnetic resonance (MR) dual-modal molecular probes in the diagnosis and treatment of breast cancer, focuses on introducing three major design strategies of the probes, and analyzes their synergistic advantages in tumor localization, metastatic lesion detection, intraoperative navigation, dynamic drug monitoring, and other aspects. Studies have shown that by combining the high-resolution anatomical information of MRI with the high-sensitivity dynamic tracking of fluorescence imaging (FI), FI-MRI dual-modal molecular imaging significantly improves the accuracy of early diagnosis and treatment visualization, and can provide an important reference for formulating precise diagnosis and treatment strategies for breast cancer.
- Open Access
- 12 September 2025
- Published by Elsevier in Clinical Radiology
- Vol. 92, 107085
Can radiomics from dynamic contrast-enhanced MRI effectively predict response to neoadjuvant chemotherapy in breast cancer?: A meta-analysis
- 12 September 2025
- Published by Elsevier in Clinical Radiology
- Vol. 92, 107085
Open AccessCan radiomics from dynamic contrast-enhanced MRI effectively predict response to neoadjuvant chemotherapy in breast cancer?: A meta-analysis
- 19 January 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 183, 111940
Radiological evaluation of pelvic venous Disorders: A comprehensive review
- 19 January 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 183, 111940
Radiological evaluation of pelvic venous Disorders: A comprehensive review